|
|
||||||
| Subject |
Sex |
Baseline NYHA Heart Failure Class |
BASELINE |
12 MONTHS |
||
|
|
||||||
| Myocardial T2* (ms) |
LVEF (%) |
Myocardial T2* (ms) |
LVEF (%) |
|||
|
|
||||||
| 1 |
F |
I |
5.2 |
59 |
6.2 |
70 |
| 2 |
M |
I |
6.0 |
28 |
6.4 |
57 |
| 3 |
M |
I |
6.5 |
50 |
10.0 |
68 |
| 4 |
M |
I |
6.4 |
42 |
9.2 |
63 |
| 5 |
M |
II |
5.6 |
30 |
6.1 |
47 |
| 6 |
M |
I |
5.0 |
57 |
5.4 |
73 |
| 7 |
F |
I |
4.8 |
60 |
5.5 |
74 |
| 8 |
F |
III |
5.3 |
43 |
7.6 |
67 |
| 9 |
F |
I |
5.0 |
54 |
8.1 |
67 |
| 10 |
M |
I |
5.7 |
58 |
6.6 |
67 |
| 11 |
F |
I |
5.4 |
49 |
10.4 |
66 |
| 12 |
F |
I |
7.3 |
61 |
11.5 |
70 |
| 13 |
F |
I |
3.7 |
61 |
4.8 |
61 |
| 14 |
F |
I |
7.4 |
60 |
13.2 |
65 |
| 15 |
F |
I |
6.1 |
56 |
7.1 |
69 |
Tanner et al. Journal of Cardiovascular Magnetic Resonance 2008 10:12 doi:10.1186/1532-429X-10-12 |
||||||